Evaluation of Phenolic Glycolipid‐I (PGL‐I) Antibody as a Multidrug Therapy (MDT) Monitor

Publisher： John Wiley & Sons Inc

E-ISSN： 1346-8138|20|1|16-20

ISSN： 0385-2407

Source： THE JOURNAL OF DERMATOLOGY, Vol.20, Iss.1, 1993-01, pp. : 16-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Significance of Antibodies to Phenolic Glycolipid‐I in Leprosy Diagnosis

By  

THE JOURNAL OF DERMATOLOGY, Vol. 19, Iss. 12, 1992-12 ,pp. : 953-958

John Wiley & Sons Inc

Access to resources Recommend Favorite

Persisters, Relapse (Reactivation), Drug Resistance and Multidrug Therapy (MDT): Uniform Diagnostic Guidelines for Leprosy Are Needed

By  

THE JOURNAL OF DERMATOLOGY, Vol. 23, Iss. 12, 1996-12 ,pp. : 905-907

John Wiley & Sons Inc

Access to resources Recommend Favorite

Renaissance of the Blocking Antibody Concept in Type I Allergy

By  

International Archives of Allergy and Immunology, Vol. 132, Iss. 1, 2003-10 ,pp. : 13-24

Karger

Access to resources Recommend Favorite

The hypervariable region 4 (HV4) and position 93 of the α chain modulate CD1d‐glycolipid binding of iNKT TCRs

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 45, Iss. 7, 2015-07 ,pp. : 2122-2133

John Wiley & Sons Inc

Access to resources Recommend Favorite

A phase I trial of an interleukin-12/23 monoclonal antibody in relapsing multiple sclerosis

By Kasper Lloyd H.   Everitt Daniel   Leist Thomas P.   Ryan Kathleen A.   Mascelli Mary Ann   Johnson Kenneth   Raychaudhuri Aparna   Vollmer Tim    

Current Medical Research and Opinion, Vol. 22, Iss. 9, 2006-09 ,pp. : 1671-1678

Informa Healthcare

Access to resources Recommend Favorite